Breast cancer is the most common non-cutaneous cancer diagnosed in women in the United States and is second only to lung cancer as the leading cause of cancer-related mortality. Although mortality rates have been dropping steadily due to a variety of factors including improved treatment modalities and screening, substantial racial differences in outcome between blacks and whites persist. Although differences in healthcare utilization and access, tumor biology, and cancer management have been elucidated as possible reasons for disparities seen it is likely that other interactions exist. The purpose of this review is therefore to present a comprehensive overview of the literature on racial disparities in breast cancer outcome and highlight potential causative factors that may contribute to disparities seen among blacks and whites with breast cancer. In addition, we make research recommendations by discussing some of the remaining gaps in knowledge that may lead to further understanding of disparities and consequently improved outcomes for all women with breast cancer.
Introduction
Projections indicate that approximately 207,000 new cases of breast cancer in the United States and 40,000 deaths will be reported in 2010 alone.(1) Although mortality rates have been dropping since 1990 due to earlier detection and improved treatment modalities, substantial racial disparities in outcome continue to persist. While the incidence rates for breast cancer in blacks are lower than whites (113 vs. 123.5 per 100,000), mortality rates are disproportionately higher (33 deaths vs. 23.9 per 100,000 cases).(1, 2) Although reasons for the racial disparities in breast cancer have not been fully elucidated, it has been suggested that factors such as differences in tumor biology, healthcare access, and disease management may contribute to the poorer outcomes observed. The purpose of this article is to present a comprehensive overview of the literature on racial disparities in breast cancer outcome and highlight potential causative factors that may contribute to disparities seen among blacks and whites with breast cancer. Specifically, we review the role of tumor biology, genetic variants in relation to survival disparities, as well as the impact of factors such as screening and detection and receipt of optimal care on poorer survival among black women with breast cancer. In addition, we discuss some of the remaining gaps in knowledge that may lead to further understanding of disparities and improved outcomes for all women with breast cancer.
Methods

A PubMed search was used to retrieve articles published in English between 1980
and 2010. MeSH terms used included "breast cancer," "disparities," "racial," "mortality,"
"incidence," "treatment," "screening," "genetics," epidemiology," and "pathology." We the overall incidence rates are higher in whites, blacks with breast cancer have a higher breast cancer specific mortality (33 vs. 23.9 per 100,000). In addition, mortality rates also differ by age-group. In 1980, blacks younger than 45 years had higher mortality rates as compared to whites in the same age group.(3) Between 1993 and 1996, breast cancer mortality rates among those aged 35 years and younger in blacks were 2 fold higher than the rates in whites. For those between 40 and 50 years the rates in blacks were 1.5 fold whites, while the two races had more or less similar outcomes for those 55 years and older.(4) The 5 year survival rates for all stages also differ by race with blacks being disadvantaged. For example, for loco-regional disease 5 year survival rates for blacks are only 72% vs. 85% for whites.(1) Table 1 gives a summary of differences in the epidemiology of breast cancer in blacks and whites.
Due to improved diagnostic and treatment modalities breast cancer mortality has declined over time, but decreases generally have been smaller and less consistent among blacks than whites.(5) In 1975, the age-adjusted death rate from breast cancer for all races was 31.4 per 100,000. By 1990, the rates had increased slightly to 33.1 deaths per 100,000, but subsequently decreased to 22.8 per 100,000 in 2007 reflecting a 27%
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Copyright © 2010 American Association for Cancer Research 6 studies in the US. (7, 9) It could be suggested that the preponderance of basal-like or hormone receptor negative tumors among black women could be due to their younger age at diagnosis, but even in older age groups, blacks are more likely than whites to present with triple negative disease. (10) Until recently, the reasons for these differences in subtypes have been unknown. Thus, it is plausible that lower vitamin D could contribute to the higher proportion of basal-like tumors among black women. Clearly, genetic, biological and epidemiological risk factors for breast cancer subtypes, particularly among black women, needs to be further investigated. However, the observation in several studies that increased risk of basal-like breast cancer is associated with higher parity, and that breastfeeding reduces this risk, warrants further public health recommendations that breastfeeding be encouraged for all women and especially for black women to reduce risk of basal-like breast cancer. Additionally, although associations between vitamin D and breast cancer in black women need to be further investigated, maintenance of adequate vitamin D levels could possibly contribute to lowering risk of aggressive breast cancer in this population. 
Racial differences in germline genetic factors
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Racial differences in detection
Although early detection with screening mammography has contributed to declines in breast cancer mortality; not all women have benefited equally. Even though blacks are less likely to undergo regular mammograms than whites, (28) it is unlikely that differences in detection account for the entirety of outcome disparities. It is difficult to estimate the attributable risk to overall outcome due to multiple other factors that influence outcome.
Factors responsible for differences in mammography rates are multifactorial and include a lower likelihood of receiving a recommendation for mammography from a health care provider, lack of insurance, or access to regular healthcare. have greater odds of having a recent mammogram than whites, (31) multivariate models suggest that fewer blacks receive regular mammograms than whites, consequently continued effort is needed to reduce access barriers for blacks not regularly screened.
Given guidelines that recommend women begin mammography at age 40 or 50, black women may be at increased risk for delayed diagnosis even if they are compliant with current screening guidelines as greater than 10% of breast cancers in blacks are diagnosed under the age of 40 years, compared to 5% of whites.(32) Therefore, the optimal age for breast cancer screening in blacks still needs to be defined. This is also particularly important given the disproportionate mortality in younger black women with breast cancer. If one considers the increased breast density in this group, mammography may not be the best choice. Perhaps race and/or age-directed screening with ultrasonography or even more sophisticated techniques with novel biomarkers ought to be developed in the future.
Racial differences in management
An important factor that also contributes to the racial gap in mortality is the observed difference in clinical management of the disease. It is plausible that black women have more comorbidities that preclude them from receiving established standards; or perhaps they are not receiving standard therapy due to cultural beliefs/distrust; or alternatively they have more problems tolerating equivalent doses of chemotherapy than their white counterparts. These are some potential reasons why black women with breast cancer frequently receive suboptimal care; however more dedicated research to fully elucidate these factors is needed. 
Copyright © 2010 American Association for Cancer Research 11 For example, a large SEER-Medicare study involving over 55,000 women showed that blacks were less likely than whites to be treated at high-quality hospitals (defined as hospitals with the top quartile rates of radiation following breast conserving surgery) and consequently less likely to receive definitive primary therapy, a finding partially explained by having surgery at a high-quality hospital.(33) When blacks do undergo breast conserving surgery, they are less likely to receive radiation than whites. In this study, the odds of radiation omission were more pronounced in blacks who lived in high-poverty areas or in areas further from cancer centers. 
Conclusion
Although several intervention programs to reduce breast cancer disparities have been instituted recently, the persistent magnitude suggests that current strategies may be inadequate. We have demonstrated that while a substantial amount of information is known about racial differences in outcome and associated factors, several gaps in knowledge exist. Addressing racial disparities in breast cancer therefore requires a multidisciplinary approach with innovative research to answer questions that are generally considered "outside the box" of traditional healthcare research. Disparities in access and quality of care may be eliminated by understanding and addressing cultural and economic barriers. Biologic differences in tumors in all racial groups need careful study to allow personalization of care and optimization of outcomes. Closing these gaps 
